Evidence map›Paper›PMID 31921836›Full record

ArticleFrontiers in cell and developmental biology2019

Thymosin β4 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion.

Aleksandra Makowiecka, Natalia Malek, Ewa Mazurkiewicz, Ewa Mrówczyńska, Dorota Nowak, Antonina Joanna Mazur

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The role ofJournal of gastrointestinal oncology · 2025
    Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives.Cellular and molecular life sciences : CMLS · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aleksandra MakowieckaDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
Natalia MalekDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
Ewa MazurkiewiczDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
Ewa MrówczyńskaDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
Dorota NowakDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
Antonina Joanna MazurDepartment of Cell Pathology, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland.
University of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymosin β4 (Tβ4), a multifunctional 44-amino acid polypeptide and a member of actin-binding proteins (ABPs), plays an important role in developmental processes and wound healing. In recent years an increasing number of data has been published suggesting Tβ4's involvement in tumorigenesis. However, Tβ4's role in melanoma tumor development still remains to be elucidated. In our study we demonstrate that Tβ4 is crucial for melanoma adhesion and invasion. For the purpose of our research we tested melanoma cell lines differing in invasive potential. Moreover, we applied shRNAs to silence

Indexed as

epithelial-mesenchymal transitionfocal adhesioninvasionmelanomamigrationthymosin β4

Identifiers

PMID31921836
PMCPMC6935720
OpenAlexW2997690955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.